Availability of Results of Trials Studying Pancreatic Adenocarcinoma over the Past 10 Years

BACKGROUND: Pancreatic adenocarcinoma (PDAC) is a lethal cancer with few therapeutic options. Availability of results is a crucial step in interventional research. Our aim was to evaluate results availability for trials in patients with PDAC and explore associated factors. MATERIALS AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellat, Anna, Boutron, Isabelle, Ravaud, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632316/
https://www.ncbi.nlm.nih.gov/pubmed/35983949
http://dx.doi.org/10.1093/oncolo/oyac156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632316/
https://www.ncbi.nlm.nih.gov/pubmed/35983949
http://dx.doi.org/10.1093/oncolo/oyac156

Ejemplares similares